The Medial Habenula and Addiction
A trio of studies look at the medial habenula, a region in the brain associated with addiction, depression, and compulsive behavior.
The Impact of GLP-1 Drugs on Reward Pathways
We examine the impact of GLP-1 drugs such as Ozempic on reward pathways and the dopamine system.
Novo Nordisk Walks Back Comments on Addiction Testing
Pharmaceutical giant Novo Nordisk is walking back comments about testing GLP-1 drugs for use in addiction treatment.
Novo Nordisk to Test GLP-1 Drugs Against Addiction
Novo Nordisk, maker of Ozempic and Wegovy, says they will start testing GLP-1 drugs for use in treating addiction.
Preventing Relapse During Recovery From Opioid Use Disorder
Researchers at the University of Maryland team up to study the genetics of relapse during recovery from opioid use disorder.
Sleep and Substance Use Disorder
New studies examine the relationship between sleep and substance use disorder.